210 related articles for article (PubMed ID: 27716735)
1. Glaucocalyxin A Ameliorates Myocardial Ischemia-Reperfusion Injury in Mice by Suppression of Microvascular Thrombosis.
Liu X; Xu D; Wang Y; Chen T; Wang Q; Zhang J; You T; Zhu L
Med Sci Monit; 2016 Oct; 22():3595-3604. PubMed ID: 27716735
[TBL] [Abstract][Full Text] [Related]
2. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
[TBL] [Abstract][Full Text] [Related]
4. Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway.
He F; Xu BL; Chen C; Jia HJ; Wu JX; Wang XC; Sheng JL; Huang L; Cheng J
Acta Pharmacol Sin; 2016 Jun; 37(6):763-71. PubMed ID: 27063216
[TBL] [Abstract][Full Text] [Related]
5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
6. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
7. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.
Liu Z; Barrett HH; Stevenson GD; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Pak KY
J Nucl Med; 2004 Jul; 45(7):1251-9. PubMed ID: 15235074
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
9. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
10. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice.
Muzumdar RH; Huffman DM; Calvert JW; Jha S; Weinberg Y; Cui L; Nemkal A; Atzmon G; Klein L; Gundewar S; Ji SY; Lavu M; Predmore BL; Lefer DJ
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1940-8. PubMed ID: 20651283
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.
Toldo S; Marchetti C; Mauro AG; Chojnacki J; Mezzaroma E; Carbone S; Zhang S; Van Tassell B; Salloum FN; Abbate A
Int J Cardiol; 2016 Apr; 209():215-20. PubMed ID: 26896627
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.
Thirunavukkarasu M; Selvaraju V; Tapias L; Sanchez JA; Palesty JA; Maulik N
J Physiol Biochem; 2015 Dec; 71(4):623-33. PubMed ID: 26342597
[TBL] [Abstract][Full Text] [Related]
13. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
15. [Tumor necrosis factor-α inhibitor protects against myocardial ischemia/reperfusion injury via Notch1 mediated inhibition of oxidative/nitrative stress in traumatic mice].
Wang X; Bai J; Xue Q; Song XF; Qiu CM; Li XC; Pei HF
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Feb; 44(2):156-60. PubMed ID: 26926510
[TBL] [Abstract][Full Text] [Related]
16. Melatonin reduces PERK-eIF2α-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia-reperfusion injury: role of RISK and SAFE pathways interaction.
Yu L; Li B; Zhang M; Jin Z; Duan W; Zhao G; Yang Y; Liu Z; Chen W; Wang S; Yang J; Yi D; Liu J; Yu S
Apoptosis; 2016 Jul; 21(7):809-24. PubMed ID: 27170343
[TBL] [Abstract][Full Text] [Related]
17. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
French CJ; Zaman AK; Sobel BE
Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
[TBL] [Abstract][Full Text] [Related]
18. CPU0213, a novel endothelin type A and type B receptor antagonist, protects against myocardial ischemia/reperfusion injury in rats.
Wang ZY; Zhang W; Li XZ; Han Y; Chen YP; Liu Z; Xie LP; Ji Y; Lu X
Braz J Med Biol Res; 2011 Nov; 44(11):1148-55. PubMed ID: 21915473
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose 4-Hydroxy-2-Nonenal (HNE) Reperfusion Therapy Displays Cardioprotective Effects in Mice After Myocardial Infarction That Are Abrogated by Genipin.
Wang YN; Gao L; Wu SY; Qin S
Med Sci Monit; 2018 Jun; 24():3702-3709. PubMed ID: 29858912
[TBL] [Abstract][Full Text] [Related]
20. Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Qian J; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y
Cardiovasc Drugs Ther; 2016 Apr; 30(2):129-41. PubMed ID: 26861490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
